Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0132 Transporter Info
Gene Name	SLC1A4
Transporter Name	Alanine/serine/cysteine/threonine transporter 1
Gene ID	6509
UniProt ID	P43007

Post-Translational Modification of This DT
Overview of SLC1A4 Modification Sites with Functional and Structural Information
Sequence	M E K S N E T N G Y L D S A Q A G P A A G P G A P G T A A G R A R R C A G F L R R Q A L V L L T V S G V L A G A G L G A A L R G L S L S R T Q V T Y L A F P G E M L L R M L R M I I L P L V V C S L V S G A A S L D A S C L G R L G G I A V A Y F G L T T L S A S A L A V A L A F I I K P G S G A Q T L Q S S D L G L E D S G P P P V P K E T V D S F L D L A R N L F P S N L V V A A F R T Y A T D Y K V V T Q N S S S G N V T H E K I P I G T E I E G M N I L G L V L F A L V L G V A L K K L G S E G E D L I R F F N S L N E A T M V L V S W I M W Y V P V G I M F L V G S K I V E M K D I I V L V T S L G K Y I F A S I L G H V I H G G I V L P L I Y F V F T R K N P F R F L L G L L A P F A T A F A T C S S S A T L P S M M K C I E E N N G V D K R I S R F I L P I G A T V N M D G A A I F Q C V A A V F I A Q L N N V E L N A G Q I F T I L V T A T A S S V G A A G V P A G G V L T I A I I L E A I G L P T H D L P L I L A V D W I V D R T T T V V N V E G D A L G A G I L H H L N Q K A T K K G E Q E L A E V K V E A I P N C K S E E E T S P L V T H Q N P A G P V A S A P E L E S K E S V L
PTM type	X-Acetylation X-N-glycosylation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Acetylation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[1]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC1A4 Methionine 1 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	201
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC1A4 Asparagine 201 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	206
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC1A4 Asparagine 206 has the potential to affect its expression or activity.
Phosphorylation
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[3]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	286
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Asparticacid 286 has the potential to affect its expression or activity.
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[3]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	209
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Histidine 209 has the potential to affect its expression or activity.
Isoleucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[3]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	287
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Isoleucine 287 has the potential to affect its expression or activity.
Serine	13 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[4] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	13
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 13 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC1A4			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	66
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 66 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC1A4			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	68
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 68 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC1A4			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	143
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 143 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC1A4			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	150
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 150 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC1A4			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	151
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 151 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC1A4			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	158
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 158 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC1A4			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	502
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 502 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC1A4			[3] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	507
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 507 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC1A4			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	521
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 521 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC1A4			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	527
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 527 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC1A4			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	530
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Serine 530 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	7
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Threonine 7 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	27
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Threonine 27 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC1A4			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Threonine 147 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC1A4			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	208
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Threonine 208 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC1A4			[3] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	506
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Threonine 506 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC1A4			[11] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	511
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Threonine 511 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[4] , [6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A4 Tyrosine 10 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[19]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	500
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC1A4 Cystine 500 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[20]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	35
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC1A4 Cystine 35 has the potential to affect its expression or activity.
Ubiquitination
Alanine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	186
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Alanine 186 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	230
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Alanine 230 has the potential to affect its expression or activity.
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[23]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	182
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Asparagine 182 has the potential to affect its expression or activity.
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[21] , [24]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Histidine 308 has the potential to affect its expression or activity.
Isoleucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[3] , [25]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	273
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Isoleucine 273 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[21] , [25]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Isoleucine 281 has the potential to affect its expression or activity.
Lysine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing cell surface expression of SLC1A4			[26]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	3
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 3 have been reported to decrease its cell surface expression.
PTM Phenomenon 2	Decreasing cell surface expression of SLC1A4			[26]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	483
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 483 have been reported to decrease its cell surface expression.
PTM Phenomenon 3	Decreasing cell surface expression of SLC1A4			[26]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	484
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 484 have been reported to decrease its cell surface expression.
PTM Phenomenon 4	Decreasing cell surface expression of SLC1A4			[26]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	493
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 493 have been reported to decrease its cell surface expression.
PTM Phenomenon 5	Decreasing cell surface expression of SLC1A4			[26]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	501
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 501 have been reported to decrease its cell surface expression.
PTM Phenomenon 6	Have the potential to influence SLC1A4			[22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	196
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 196 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC1A4			[23]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	480
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 480 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC1A4			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	528
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Lysine 528 has the potential to affect its expression or activity.
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[21] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Serine 203 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	263
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Serine 263 has the potential to affect its expression or activity.
Tryptophan	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[21] , [23]
Role of PTM	Potential impacts
Modified Residue	Tryptophan	Modified Location	264
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Tryptophan 264 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[3] , [25]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	195
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Tyrosine 195 has the potential to affect its expression or activity.
Valine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A4			[22] , [23]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	185
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Valine 185 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A4			[23]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	260
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A4 Valine 260 has the potential to affect its expression or activity.

References
1	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2	Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009 Apr;27(4):378-86.
3	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
4	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
5	Targeted analysis of tyrosine phosphorylation by immuno-affinity enrichment of tyrosine phosphorylated peptides prior to mass spectrometric analysis. Methods. 2012 Feb;56(2):268-74.
6	Large-Scale Reanalysis of Publicly Available HeLa Cell Proteomics Data in the Context of the Human Proteome Project. J Proteome Res. 2018 Dec 7;17(12):4160-4170.
7	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
8	Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
9	Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis. J Proteome Res. 2015 Dec 4;14(12):5341-7.
10	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
12	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
13	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
14	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
15	Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
16	FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides. J Proteome Res. 2015 Dec 4;14(12):5077-87.
17	Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines. PLoS One. 2016 Jun 30;11(6):e0157290.
18	Synthesizing Signaling Pathways from Temporal Phosphoproteomic Data. Cell Rep. 2018 Sep 25;24(13):3607-3618.
19	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
20	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
21	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
22	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
23	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
24	Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin. J Proteome Res. 2012 Feb 3;11(2):796-807.
25	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.
26	Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell Biosci. 2021 Apr 17;11(1):75.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence